We haveexciting news! Ten Academic research teams and early stage companies were named as finalists in the2018 Diabetes Innovation Challenge, a world-wide competition to identify, nurture and advance innovative scientific and clinical solutions for diabetes.
This wouldn’t be possible without the generous support of the community and our lead sponsors, The Leona M. and Harry B. Helmsley Charitable Trust and JDRF. Thank you!
The finalists offer proposals in four categories that are critical to advancing the care of people with diabetes including:
Automated Insulin Devices (Artificial Pancreas) and related components such as novel glucose sensing, insulin delivery systems, and cellular therapy delivery technologies
AP Advance: An autonomous and discreet diabetes management system mimicking a healthy pancreas
Cam Med LLC: An ultra-thin, flexible, bandage-like patch pump that delivers multiple drugs at minimal cost
Micromedics, Inc.: A portable bio-artificial pancreas using microfabrication technology to mimic the pancreas
Diagnostics such as novel low-cost tests for research and screening; early diagnosis and prevention; autoantibodies, C- peptide, or other markers such as beta cell death and risk of diabetic complications
Bonbouton: Early detection of signals that can lead to foot ulcers and amputations in diabetic patients
VOTIS Subdermal Imaging Technologies, Ltd.: Pathology of the diabetic foot
Therapeutics including smart insulins, glucagons, immune-modulating therapies, beta cell regeneration and treatments for diabetic complications
Protomer Technologies Inc.: Weekly injectable glucagon that senses low blood sugar and automatically activates in the body
Ridgeline Therapeutics:Oral medication to treat Type 2 diabetes by selectively shrinking fat deposits
University of Southern California: Device to maintain oxygen levels in the eye and prevent blindness
Technology Design/Disease Management solutions for new and disruptive approaches to the use of information and communication technologies to support diabetes management
On May 21, 2018 from 2 to 7PM at the Royal Sonesta Boston, the ten finalists will pitch their solutions during a live event and a panel of judges will select three winners. We will also announce the People's Choice winner.
Attendees will have the opportunity to speak with the 10 finalists and the 20 semifinalists and view their poster presentations.
The 2018 Diabetes Innovation Challenge is generously supported by the following sponsors:
General Sponsors: Fortunato Intellectual Property Law HealthAdvances Locust Walk Moody, Famiglietti & Andronico, LLP ProSciento Sansum Diabetes Research Institute Scott Miller Communications Stacey Shipman
And a Thank You to our Individual Sponsors: Team Carly Rocks Foundation The Claire Friedlander Family Foundation The Geoffrey S. Rehnert Family Charitable Fund